Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJCXV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,603
Award facts
- Contract value 100% obligated
- $25,603.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,603.45 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, making this delivery order part of the federal government's pharmaceutical supply chain supporting military healthcare systems and other government entities.
As a child order under the DLA's comprehensive pharmaceutical prime vendor agreement, this delivery order reflects AmerisourceBergen's role as a critical supplier of specialty and brand-name medications to military and veteran healthcare programs. The contract demonstrates the company's capacity to fulfill federal medical procurement requirements through its extensive distribution network, supporting the Defense Health Agency and related healthcare systems with specialized pharmaceutical commodities. This delivery order is one of numerous transactions executed under the broader SPE2DX vehicle, which enables flexible pharmaceutical procurement across multiple therapeutic domains for global military medical support operations.
Quick answers
Who was awarded contract SPE2DB25FJCXV?
SPE2DB25FJCXV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FJCXV worth?
The government has obligated $25,603 on SPE2DB25FJCXV.
Is contract SPE2DB25FJCXV an order under another contract?
Yes. SPE2DB25FJCXV is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB25FJCXV competed?
The extent of competition for SPE2DB25FJCXV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award